| Baseline control patientsa | Recurrent infections | ||
---|---|---|---|---|
D0 | D0 | D1 | Day of parasite recurrence | |
pfmdr1 PCR success rate n/N, Â % | 45/46, 97.8 | 35/35, 100 | 34/35, 97.2 | 28/35, 80 |
pfmdr1 N86 prevalence, n/N, % (95% CI) | 43/45, 95.6 (84.9–99.5)b | 34/35, 97.1 (85–100) | 33/34, 97.1 (84.7–100) | 28/28, 100 (87.7–100) |
pfk13 PCR success rate n/N, % | 42/46, 91.3 | 34/35, 97.1 | 30/35, 85.7 | 26/35, 74 |
Prevalence of SNPs in K13 n/N, % (95% CI) | 2/35, 5.9 (0.7–19.7) | 2/34, 5.9 (0.7–19.7) | ND | 1/26, 3.9 (0.1–19.6) |